SARS-CoV-2, Influenza
3 competing products in clinical development for SARS-CoV-2, Influenza.
Pipeline by Phase
Phase 22
Phase 31
All Products (3)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| mRNA-1083.1 | Moderna | Phase 2 | Completed | 0 |
| mRNA-1083 | Moderna | Phase 3 | Completed | 0 |
| mRNA-1073 | Moderna | Phase 2 | Completed | 0 |